tert-Butyl (S)-(1-(3,6-dibromopyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)carbamate manufacturers
|
| | tert-Butyl (S)-(1-(3,6-dibromopyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)carbamate Basic information |
| Product Name: | tert-Butyl (S)-(1-(3,6-dibromopyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)carbamate | | Synonyms: | Carbamic acid, N-[(1S)-1-(3,6-dibromo-2-pyridinyl)-2-(3,5-difluorophenyl)ethyl]-, 1,1-dimethylethyl ester;tert-Butyl (S)-(1-(3,6-dibromopyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)carbamate;tert-butyl N-[(1S)-1-(3,6-dibromopyridin-2-yl)-2-(3,5-difluorophenyl)ethyl]carbamate;N-[(1S)-1-(3,6-dibromo-2-pyridinyl)-2-(3,5-difluorophenyl)ethyl]-, 1,1-dimethylethyl ester;Carbamic acid, N-[(1S)-1-(3,6-dibromo-2-pyridinyl)-2-(3,5-difluorophenyl)ethyl]-, 1,1-dimethylethyl este | | CAS: | 1620056-47-4 | | MF: | C18H18Br2F2N2O2 | | MW: | 492.15 | | EINECS: | | | Product Categories: | | | Mol File: | 1620056-47-4.mol |  |
| | tert-Butyl (S)-(1-(3,6-dibromopyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)carbamate Chemical Properties |
| Boiling point | 499.1±45.0 °C(Predicted) | | density | 1.574±0.06 g/cm3(Predicted) | | pka | 10.42±0.46(Predicted) | | InChI | InChI=1S/C18H18Br2F2N2O2/c1-18(2,3)26-17(25)23-14(16-13(19)4-5-15(20)24-16)8-10-6-11(21)9-12(22)7-10/h4-7,9,14H,8H2,1-3H3,(H,23,25)/t14-/m0/s1 | | InChIKey | XKLGEKSJSJYONN-AWEZNQCLSA-N | | SMILES | C(OC(C)(C)C)(=O)N[C@H](C1=NC(Br)=CC=C1Br)CC1=CC(F)=CC(F)=C1 |
| | tert-Butyl (S)-(1-(3,6-dibromopyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)carbamate Usage And Synthesis |
| Description |
Tert-Butyl (S)-(1-(3,6-dibromopyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)carbamate is a solid, it can be used to synthesize lenacapavir sodium.
| | Uses | tert-Butyl (S)-(1-(3,6-dibromopyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)carbamate is a pharmaceutical intermediate compound that can be used to prepare capsid inhibitors for the treatment of HIV. |
| | tert-Butyl (S)-(1-(3,6-dibromopyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)carbamate Preparation Products And Raw materials |
|